{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:18:49Z","timestamp":1790176729961,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.humimm.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T16:00:51Z","timestamp":1486656051000},"page":"336-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Relationship between Mean Fluorescence Intensity and C1q\/C3d-fixing capacities of anti-HLA antibodies"],"prefix":"10.1016","volume":"78","author":[{"given":"Guillaume","family":"Claisse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Absi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Cognasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Alamartine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Mariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.humimm.2017.02.003_b0005","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence: attributing causes of kidney transplant loss","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.humimm.2017.02.003_b0010","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.humimm.2017.02.003_b0015","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1600-6143.2009.02813.x","article-title":"Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies","volume":"9","author":"Loupy","year":"2009","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.humimm.2017.02.003_b0020","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2009.02985.x","article-title":"Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation","volume":"10","author":"Gloor","year":"2010","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.humimm.2017.02.003_b0025","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure","volume":"9","author":"Hidalgo","year":"2009","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.humimm.2017.02.003_b0030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"issue":"10","key":"10.1016\/j.humimm.2017.02.003_b0035","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1111\/j.1600-6143.2006.01503.x","article-title":"Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure","volume":"6","author":"Campos","year":"2006","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.humimm.2017.02.003_b0040","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.TP.0000136966.63957.E2","article-title":"Human leukocyte antigen antibodies and human complement activation: role of IgG subclass, specificity, and cytotoxic potential","volume":"78","author":"Kushihata","year":"2004","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.humimm.2017.02.003_b0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2014111120","article-title":"IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury","volume":"27","author":"Lefaucheur","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.humimm.2017.02.003_b0050","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/TP.0b013e3182888db6","article-title":"The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes","volume":"95","author":"Freitas","year":"2013","journal-title":"Transplant. J."},{"issue":"9","key":"10.1016\/j.humimm.2017.02.003_b0055","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: comparison of MFI, C1q, and titer information: determining antibody strength","volume":"15","author":"Tambur","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.humimm.2017.02.003_b0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/MNH.0000000000000069","article-title":"New insights in antibody-mediated rejection","volume":"23","author":"Gosset","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"13","key":"10.1016\/j.humimm.2017.02.003_b0065","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.humimm.2017.02.003_b0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","author":"Sicard","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.humimm.2017.02.003_b0075","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.humimm.2011.07.001","article-title":"Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads","volume":"72","author":"Chen","year":"2011","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2017.02.003_b0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","article-title":"Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients","volume":"30","author":"Chin","year":"2011","journal-title":"J. Heart Lung Transplant."},{"issue":"3","key":"10.1016\/j.humimm.2017.02.003_b0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation","volume":"91","author":"Yabu","year":"2011","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.humimm.2017.02.003_b0090","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1600-6143.2011.03985.x","article-title":"Pretransplant donor-specific HLA Class-I and -II antibodies are associated with an increased risk for kidney graft failure: HLA antibodies and kidney graft survival","volume":"12","author":"Otten","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2017.02.003_b0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1399-3046.2011.01599.x","article-title":"Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss: C1q(+) DSA increase risk of allograft loss","volume":"16","author":"Sutherland","year":"2012","journal-title":"Pediatr. Transplant."},{"issue":"6176","key":"10.1016\/j.humimm.2017.02.003_b0100","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.1248943","article-title":"Complement is activated by IgG hexamers assembled at the cell surface","volume":"343","author":"Diebolder","year":"2014","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.humimm.2017.02.003_b0105","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/TP.0000000000000699","article-title":"C1q-binding activity of de novo donor-specific HLA antibodies in renal transplant recipients with and without antibody-mediated rejection","volume":"99","author":"Yell","year":"2015","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.humimm.2017.02.003_b0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients","volume":"32","author":"Zeevi","year":"2013","journal-title":"J. Heart Lung Transplant."},{"issue":"2","key":"10.1016\/j.humimm.2017.02.003_b0115","first-page":"106","article-title":"Understanding waterfall plots","volume":"34","author":"Gillespie","year":"2012","journal-title":"J. Adv. Pract. Oncol."},{"issue":"12","key":"10.1016\/j.humimm.2017.02.003_b0120","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1111\/ajt.13452","article-title":"Assessing HLA antibody strength: have we thought about everything?: assessing HLA antibody strength","volume":"15","author":"Visentin","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.humimm.2017.02.003_b0125","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.transproceed.2013.11.011","article-title":"Significance of C1q-fixing donor-specific antibodies after kidney transplantation","volume":"46","author":"Thammanichanond","year":"2014","journal-title":"Transplant. Proc."},{"issue":"5","key":"10.1016\/j.humimm.2017.02.003_b0130","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/TP.0b013e31827b3dc3","article-title":"Systematic comparison of four cell- and luminex-based methods for assessment of complement-activating HLA antibodies","volume":"95","author":"Lachmann","year":"2013","journal-title":"Transplant. J."},{"issue":"2","key":"10.1016\/j.humimm.2017.02.003_b0135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2014040326","article-title":"Non-complement-binding de novo donor-specific anti-HLA antibodies and kidney allograft survival","volume":"27","author":"Guidicelli","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.humimm.2017.02.003_b0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/TP.0000000000000203","article-title":"Determinants of C1q binding in the single antigen bead assay","volume":"98","author":"Schaub","year":"2014","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.humimm.2017.02.003_b0145","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/ajt.13700","article-title":"Acquisition of C3d-binding activity bu de novo donor-specific HLA antibodies correlates with graft loss in nonsensitized pediatric kidney recipients","volume":"16","author":"Comoli","year":"2016","journal-title":"Am. J. Transplant."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019888591730023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019888591730023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T12:23:37Z","timestamp":1536063817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019888591730023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S019888591730023X"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2017.02.003","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between Mean Fluorescence Intensity and C1q\/C3d-fixing capacities of anti-HLA antibodies","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}